Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial is a research paper published in The Journal of Experimental Medicine (2020). On theSindex it has a DataRank of 1.5. It has been cited 39 times, with 39 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.553
From this paper's citation signal
Citation Network Contribution
0.920
From 38 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 39 citers.
National Institutes of Health
Grant: P01 CA049605
The Leukemia and Lymphoma Society
Grant: LLS TRP-6010-14
NCI NIH HHS
Grant: R35 CA197353
FWCI
3.80
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals